FOLLICULAR LYMPHOMA GRADE 3B
Clinical trials for FOLLICULAR LYMPHOMA GRADE 3B explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA GRADE 3B trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA GRADE 3B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Ready-Made' cell therapy for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new type of cell therapy called P-CD19CD20-ALLO1 for adults with aggressive B-cell lymphomas that have come back or not responded to standard treatments. The therapy uses genetically modified immune cells from a donor (not the patient…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3B
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New 'Living Drug' trial offers hope for lymphoma patients out of options
Disease control Recruiting nowThis is a first-in-human study testing the safety and early effectiveness of a new cell therapy called SynKIR-310. It is for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments, including other CAR-T therapies. The main goa…
Matched conditions: FOLLICULAR LYMPHOMA GRADE 3B
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC